Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 9 | 2025 | 62 | 2.330 |
Why?
|
| Hypertension, Pulmonary | 2 | 2024 | 102 | 0.990 |
Why?
|
| Cystic Fibrosis | 2 | 2019 | 160 | 0.990 |
Why?
|
| Hemodynamics | 1 | 2024 | 235 | 0.800 |
Why?
|
| Transcriptome | 2 | 2024 | 357 | 0.760 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 55 | 0.590 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 79 | 0.590 |
Why?
|
| Sweat | 1 | 2018 | 9 | 0.580 |
Why?
|
| Chlorides | 1 | 2018 | 49 | 0.580 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1099 | 0.580 |
Why?
|
| Asthma | 2 | 2018 | 313 | 0.530 |
Why?
|
| Anticonvulsants | 1 | 2018 | 136 | 0.520 |
Why?
|
| Mass Screening | 2 | 2018 | 354 | 0.460 |
Why?
|
| Respiration, Artificial | 3 | 2025 | 288 | 0.410 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 29 | 0.410 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 39 | 0.400 |
Why?
|
| MicroRNAs | 3 | 2024 | 392 | 0.400 |
Why?
|
| Community Health Services | 1 | 2014 | 102 | 0.400 |
Why?
|
| Public Health Administration | 1 | 2014 | 81 | 0.390 |
Why?
|
| Infant, Newborn | 9 | 2025 | 2871 | 0.370 |
Why?
|
| Mediastinal Diseases | 1 | 2011 | 7 | 0.360 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2011 | 32 | 0.350 |
Why?
|
| Infant, Premature | 5 | 2024 | 327 | 0.330 |
Why?
|
| Premature Birth | 2 | 2023 | 150 | 0.320 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2024 | 600 | 0.300 |
Why?
|
| Female | 11 | 2025 | 28277 | 0.250 |
Why?
|
| Humans | 17 | 2025 | 52441 | 0.240 |
Why?
|
| Tracheobronchomalacia | 1 | 2025 | 10 | 0.230 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2024 | 2 | 0.220 |
Why?
|
| Infant | 8 | 2025 | 3709 | 0.220 |
Why?
|
| Air Pollution, Indoor | 1 | 2024 | 27 | 0.220 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2024 | 53 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2024 | 4046 | 0.220 |
Why?
|
| Child | 8 | 2024 | 7194 | 0.210 |
Why?
|
| Trachea | 1 | 2024 | 55 | 0.210 |
Why?
|
| Infant, Low Birth Weight | 1 | 2024 | 77 | 0.210 |
Why?
|
| Home Care Services | 1 | 2024 | 70 | 0.200 |
Why?
|
| Adolescent | 3 | 2019 | 6713 | 0.200 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1028 | 0.180 |
Why?
|
| Male | 7 | 2025 | 26874 | 0.180 |
Why?
|
| RNA, Messenger | 1 | 2024 | 1134 | 0.170 |
Why?
|
| Tourette Syndrome | 1 | 2018 | 10 | 0.150 |
Why?
|
| False Positive Reactions | 1 | 2018 | 64 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 458 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1202 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 396 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 870 | 0.110 |
Why?
|
| Respiratory Function Tests | 2 | 2024 | 90 | 0.110 |
Why?
|
| New York | 1 | 2014 | 51 | 0.110 |
Why?
|
| Cultural Competency | 1 | 2014 | 56 | 0.100 |
Why?
|
| Tracheostomy | 2 | 2025 | 76 | 0.100 |
Why?
|
| Minority Groups | 1 | 2014 | 136 | 0.100 |
Why?
|
| Health Education | 1 | 2014 | 157 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2019 | 1724 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 224 | 0.090 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 202 | 0.090 |
Why?
|
| Morbidity | 2 | 2022 | 137 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 64 | 0.090 |
Why?
|
| Patient Discharge | 2 | 2024 | 320 | 0.090 |
Why?
|
| Adult | 2 | 2019 | 14205 | 0.080 |
Why?
|
| Smoking | 1 | 2014 | 514 | 0.080 |
Why?
|
| Biopsy | 1 | 2011 | 594 | 0.080 |
Why?
|
| Young Adult | 1 | 2019 | 4346 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 977 | 0.070 |
Why?
|
| United States | 3 | 2024 | 5215 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1677 | 0.070 |
Why?
|
| Ventilator Weaning | 1 | 2024 | 21 | 0.050 |
Why?
|
| Forced Expiratory Volume | 1 | 2024 | 52 | 0.050 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2024 | 50 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2024 | 485 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2023 | 42 | 0.050 |
Why?
|
| Child Day Care Centers | 1 | 2022 | 8 | 0.050 |
Why?
|
| Steroids | 1 | 2022 | 61 | 0.050 |
Why?
|
| Outpatients | 1 | 2023 | 128 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2025 | 6694 | 0.050 |
Why?
|
| Parents | 1 | 2024 | 339 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 498 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2022 | 106 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 121 | 0.040 |
Why?
|
| Aged | 1 | 2014 | 10242 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1223 | 0.040 |
Why?
|
| Middle Aged | 1 | 2014 | 13133 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2024 | 5508 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 2642 | 0.030 |
Why?
|